Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FNA - Paragon 28, Inc.


Close
10.23
3.260   31.867%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:22:33 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$6.97
3.26
46.77%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 19%
Liquidity 34%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
2.39%
1 Month
4.16%
3 Months
62.50%
6 Months
61.73%
1 Year
-17.58%
2 Year
-51.35%
Key data
Stock price
$10.23
P/E Ratio 
-12.08
DAY RANGE
$6.97 - $10.06
EPS 
-$0.70
52 WEEK RANGE
$5.02 - $14.79
52 WEEK CHANGE
-$19.07
MARKET CAP 
695.072 M
YIELD 
N/A
SHARES OUTSTANDING 
83.542 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$618,030
AVERAGE 30 VOLUME 
$523,065
Company detail
CEO: Albert DaCosta
Region: US
Website: paragon28.com
Employees: 343,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems. It offers gorilla plating systems, including gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities.

Recent news